Abstract
As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin-peginterferon-α therapy.
Keywords:
Abu Dhabi; MERS-CoV; Middle East respiratory syndrome coronavirus; UAE; United Arab Emirates; WHO; World Health Organization; fatal outcome; influenza-like illness; pregnancy; surveillance; treatment; viruses.
Publication types
-
Case Reports
-
Historical Article
MeSH terms
-
Adult
-
Antiviral Agents / therapeutic use
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / history
-
Coronavirus Infections / virology*
-
Drug Therapy, Combination
-
Fatal Outcome
-
Female
-
History, 21st Century
-
Humans
-
Middle East Respiratory Syndrome Coronavirus* / classification
-
Middle East Respiratory Syndrome Coronavirus* / genetics
-
Pregnancy
-
Pregnancy Complications, Infectious / diagnosis
-
Pregnancy Complications, Infectious / drug therapy
-
Pregnancy Complications, Infectious / epidemiology*
-
Pregnancy Complications, Infectious / history
-
Pregnancy Complications, Infectious / virology*
-
United Arab Emirates / epidemiology